Promising Chinese Stocks To Consider – April 1st

Charming Medical, Diageo, and Regencell Bioscience are the three Chinese stocks to watch today, according to MarketBeat’s stock screener tool. Chinese stocks are equity securities issued by companies based in or deriving most of their revenue from China, and include shares listed on mainland exchanges (A?shares/B?shares), Hong Kong (H?shares), and foreign exchanges as ADRs/DRs. For investors they provide exposure to China’s economy and growth opportunities but also carry country-specific risks such as regulatory changes, governance differences, currency fluctuations, and varying market-access rules. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Charming Medical (MCTA)

We are a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products. We offer a wide range of beauty, wellness, and postpartum services and products rooted and influenced by the principles and practices of TCM, such as the use of herbal ingredients, acupuncture techniques, Tuina massage, and dietary guidance.

Read Our Latest Research Report on MCTA

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

Read Our Latest Research Report on DEO

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Read Our Latest Research Report on RGC

Recommended Stories